Determining the association of insurance coverage and survival outcomes in patients with olfactory neuroblastoma utilizing machine learning.

We use machine learning to examine health insurance and mortality in olfactory neuroblastoma. Private insurance significantly improved survival even after adjusting for confounders. The regression model also found no statistical difference between Medicare and no insurance.